Table 2 Intensity and Amount of MGSA in 37 Malignant Melanomas, Related to Patient Follow-Up Status in 27
From: Melanoma Growth Stimulatory Activity in Primary Malignant Melanoma: Prognostic Significance
Patient Status | 1+ | 2+ | 3+ | Immunostain | Amount |
|---|---|---|---|---|---|
≤50% | >50% | ||||
Alive (17) | |||||
Free of disease (13) | 1 | 4 | 8 | 1 | 12 |
Recurred, re-excised (3) | 2 | 1 | 1 | 2 | |
Alive with disease (1) | 1 | 1 | |||
Dead (10) | |||||
Secondary to melanoma (5) | 1 | 2 | 2 | 1 | 4 |
Intercurrent disease (5) | 2 | 1 | 2 | 3 | 2 |
Unknown (10) | 2 | 3 | 5 | 10 | |
Total (37) | 6 | 12 | 19 | 6 | 31 |